NYSE:ASPNChemicals
A Look At Aspen Aerogels (ASPN) Valuation After Steep Losses And Manufacturing Impairment
Why Aspen Aerogels is back in focus
Aspen Aerogels (ASPN) is back on investors’ radar after reporting a sharp year over year revenue decline, a large full year net loss, a sizeable impairment charge, and guidance indicating continued losses.
See our latest analysis for Aspen Aerogels.
The stock’s recent swings reflect this reset in expectations, with a 7 day share price return showing a 13.57% decline and a 1 year total shareholder return indicating a 59% loss, highlighting how pressure has...